Seoul – October 12, 2026 -- Parkinson's patients taking the investigational drug solengepras gained an average of 36 more minutes of "good" movement time per day than those on their regular medication alone, and the drug will now be submitted to the U.S. Food and Drug Administration for approval.

ARISE trial results presented at the MDS International Congress

The data from the ARISE clinical trial were presented at the International Congress of Parkinson's Disease and Movement Disorders. Patients, who can have difficulty moving, also reported improvements in measures of daily living, according to the source.

Patient-reported outcomes were positive across all measured areas of daily living. Drooling and saliva control showed the most significant self-reported change, while improved daytime sleepiness was also recorded.

Beijing – October 12, 2026 -- T-MAXIMUM PHARMACEUTICAL has received FDA clearance to start a Phase 2 study of MT027, its B7-H3-targeted allogeneic CAR-T therapy, in patients with brain metastases from lung and breast cancer. It is the second Phase 2 program for the asset to clear the agency.

MT027 now has two FDA-cleared Phase 2 programs in intracranial solid tumors

The FDA previously cleared a Phase 2 study of MT027 in recurrent glioblastoma. The therapy holds Orphan Drug Designation and Fast Track Designation. The two programs give T-MAXIMUM a dual-indication portfolio covering both primary and metastatic intracranial solid tumors.

Delray Beach – October 12, 2026 -- The global oxygen scavenger market will grow from USD 3.49 billion in 2026 to USD 4.99 billion by 2031, a compound annual growth rate of 7.4%, according to a MarketsandMarkets forecast.

Asia Pacific holds 36.5% of 2026 revenue and is forecast to grow fastest

Asia Pacific is the largest regional market, with a 36.5% revenue share in 2026. MarketsandMarkets also expects it to be the fastest-growing region through 2031. It cites industrialization, urbanization and expanding food processing and pharmaceutical manufacturing in China, India, Japan, South Korea and Southeast Asia. China, India and Japan are investing heavily in pharmaceutical production, food processing, industrial infrastructure and advanced packaging systems.

Delray Beach – October 12, 2026 -- The global rodenticides market is estimated at USD 6.61 billion in 2026 and is projected to reach USD 8.83 billion by 2031, a 6.0% CAGR, according to MarketsandMarkets.

North America held 31.3% of 2025 revenue as Europe is expected to keep a significant share

North America accounted for the largest regional revenue share in 2025, at 31.3%. Europe is expected to hold a significant share of the global market, driven by rising rodent infestations in urban, industrial and agricultural sectors and by stringent food safety and public health rules. Well-developed pest control services and efficient distribution systems add to its position. Asia Pacific is identified as an important growth region, supported by rapid urbanization, expanding agriculture and food-storage infrastructure.

Delray Beach – October 12, 2026 -- The global low-power brushless DC (BLDC) motor market will grow from USD 6.59 billion in 2026 to USD 9.69 billion by 2031, a compound annual growth rate of 8.0%, according to MarketsandMarkets. The 2025 market size stood at USD 6.11 billion.

Asia Pacific is forecast to grow fastest at 8.8% CAGR through 2031

Asia Pacific is expected to post the highest regional CAGR of 8.8%. MarketsandMarkets attributes the growth to industrial development, expanding manufacturing, rising automation and demand for energy savings. China, Japan, South Korea, India and ASEAN countries have invested heavily in robotics, industrial automation, electric transportation, smart appliances and battery devices.

Hong Kong – – October 12, 2026 -- Euro Tech Holdings Company Limited (Nasdaq: CLWT) has entered Norway through a 50/50 joint venture with Sea Clean AS, giving the Hong Kong-based company a Scandinavian base for its PortoBallast ballast water treatment system.

The venture, named CleanPACT Environmental and Marine Engineering AS, was signed between Sea Clean and Euro Tech's wholly owned subsidiary, Euro Tech Global Pte Ltd.

CleanPACT will operate as a customer experience center for port ballast water treatment

The center will offer hands-on demonstrations, expert servicing, realistic simulations and tailored training. It is built around PortoBallast, a next-generation mobile hybrid system. The system is designed to treat ballast water from UV and electrolysis-type treatment systems aboard vessels that fail to meet discharge compliance requirements.

Houston – October 12, 2026 -- Frost & Sullivan has named Tatsoft a Visionary Leader in the Frost RadarTM: SCADA for Industrial Control Environments, 2026, and Tatsoft is pairing the ranking with a fixed-price migration service for legacy SCADA and HMI applications. The Frost RadarTM benchmarks SCADA platforms on two indices, innovation and growth. Visionary Leaders are the vendors with a strong balance of both.

Frost & Sullivan ties the ranking to FrameworX 10.1 architecture, released in May 2026

The analyst firm's profile centers on FrameworX 10.1 and the stack beneath it. That stack includes a current .NET runtime (.NET 10) and WebAssembly, so one build runs on desktop, web and mobile. It deploys on Windows, Linux and Docker, with a Unified Namespace (UNS) and knowledge graph built into the platform. Engineers extend applications in C#, VB.NET and Python 3.

Palo Alto – October 12, 2026 -- insidepacket has announced the AI Access Platform, which connects enterprises to GPU and neocloud providers through private network paths that can be activated in minutes. The platform is planned for introduction in Europe, first with Zayo Europe.

Platform comes in two models for GPU clouds and operators

The first model is a dedicated on-ramp that a GPU cloud sells under its own brand. The second is an operator layer that exposes many GPU clouds to the operator's enterprise customers. The underlying NaaS platform has been in production in the US since September 2025 and in Europe since mid 2026.

Sydney – October 12, 2026 -- The Safety Review Committee (SRC) for Racura Oncology's HARNESS-1 trial has cleared lead drug RC220 to escalate to 100 mg/m2, after finding no dose-limiting toxicities in either Cohort 1 patient. The Phase 1a/b study combines RC220 with osimertinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC).

Both Cohort 1 patients received RC220 at 50 mg/m2 by intravenous infusion alongside osimertinib at 80 mg daily. The second patient has received three RC220 doses, given 21 days apart, with no dose-limiting toxicities or treatment-related safety concerns.

Plover, Wisconsin – October 12, 2026 -- More than 18,000 votes were cast in this year's "Top Companies for Women to Work in Trucking" program, which Redefining the Road magazine, the official magazine of the Women In Trucking Association (WIT), used to release its 2026 list.

The program is in its ninth year. The magazine created the award in 2018 to support WIT's mission of promoting companies focused on the employment and advancement of women in trucking, according to Lana Nichols, interim president and CEO of WIT.

Voting by industry professionals determines the Elite 30

Every nomination is evaluated against established criteria before transportation professionals from across the industry vote on the final honorees, according to Brian Everett, group publisher and editorial director of Redefining the Road. The companies with the most votes make up the "Elite 30" of the 2026 list.